Companies are not allowed to make a generic Jentadueto (linagliptin/metformin) product at this time, as the drug is protected by patents. The first patent is scheduled to expire in April 2017, which would be the earliest predictable date that a generic version could become available. It is generally more cost effective to take Jentadueto rather than the individual components separately.
Can I Buy Generic Jentadueto?Jentadueto™ (linagliptin/metformin) is a prescription medication approved for treating type 2 diabetes. It contains linagliptin, which belongs to a relatively new class of diabetes medications known as dipeptidyl peptidase-4 (DPP-4) inhibitors. It also contains metformin, an older diabetes medication.
Jentadueto is marketed by Boehringer Ingelheim Pharmaceuticals, Inc., and Eli Lilly and Company. Because this drug is protected by patents that have not yet expired, there are no generic versions of Jentadueto available in the United States.
When Will a Generic Version Be Available?The first patent for Jentadueto is set to expire in April 2017. This is the earliest predictable date that a generic version could become available.
However, other circumstances could come up to delay or shorten the exclusivity period. This could include such things as lawsuits or patents for new Jentadueto uses. Once the patent expires, there may be several companies that manufacture a generic Jentadueto drug.
What About Taking Linagliptin and Metformin Separately?In general, most people will find that taking Jentadueto instead of taking the individual components (linagliptin and metformin) separately will be most cost effective. However, rare situations may arise in which it might be less expensive to take the two components separately. This is most likely to occur if an insurance company will cover the two components separately but will not cover Jentadueto.